| First Author | Xiong Y | Year | 1993 |
| Journal | Nature | Volume | 366 |
| Issue | 6456 | Pages | 701-4 |
| PubMed ID | 8259214 | Mgi Jnum | J:42670 |
| Mgi Id | MGI:1097963 | Doi | 10.1038/366701a0 |
| Citation | Xiong Y, et al. (1993) p21 is a universal inhibitor of cyclin kinases [see comments]. Nature 366(6456):701-4 |
| abstractText | Deregulation of cell proliferation is a hallmark of neoplastic transformation. Alteration in growth control pathways must translate into changes in the cell-cycle regulatory machinery, but the mechanism by which this occurs is largely unknown. Compared with normal human fibroblasts, cells transformed with a variety of viral oncoproteins show striking changes in the subunit composition of the cyclin-dependent kinases (CDKs). In normal cells, CDKs exist predominantly in multiple quaternary complexes, each containing a CDK, cyclin, proliferating cell nuclear antigen and the p21 protein. However, in many transformed cells, proliferating cell nuclear antigen and p21 are lost from these multiprotein enzymes. Here we have investigated the significance of this phenomenon by molecular cloning of p21 and in vitro reconstitution of the quaternary cell-cycle kinase complexes. We find that p21 inhibits the activity of each member of the cyclin/CDK family. Furthermore, overexpression of p21 inhibits the proliferation of mammalian cells. Our results indicate that p21 may be a universal inhibitor of cyclin kinases. |
